Renhe Pharmacy Co Ltd Market Cap ($1.06 Billion)
Market Cap & Net Worth: Renhe Pharmacy Co Ltd (000650)
Renhe Pharmacy Co Ltd market cap. Renhe Pharmacy Co Ltd (SHE:000650) has a market capitalization of $1.06 Billion (CN¥7.21 Billion) as of November 5, 2026. Listed on the SHE stock exchange, this China-based company holds position #8396 globally and #1912 in its home market, demonstrating a 1.98% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Renhe Pharmacy Co Ltd's stock price CN¥5.15 by its total outstanding shares 1399938234 (1.40 Billion). Also see 000650 operating cash flow for how efficiently the company converts equity into cash flow.
Renhe Pharmacy Co Ltd Market Cap History (2015–2026)
Renhe Pharmacy Co Ltd market cap history from 2015 to 2026. Data shows change from $1.84 Billion to $1.06 Billion (-4.17% CAGR). Check Renhe Pharmacy Co Ltd stock price for real-time trading data and today's change.
Renhe Pharmacy Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Renhe Pharmacy Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 000650 net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.33x
Renhe Pharmacy Co Ltd's market cap is 0.33 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.94x
Renhe Pharmacy Co Ltd's market cap is 2.94 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.23 Billion | $3.57 Billion | $372.38 Million | 0.34x | 3.29x |
| 2017 | $920.97 Million | $3.84 Billion | $380.23 Million | 0.24x | 2.42x |
| 2018 | $985.86 Million | $4.40 Billion | $506.46 Million | 0.22x | 1.95x |
| 2019 | $1.15 Billion | $4.58 Billion | $537.83 Million | 0.25x | 2.14x |
| 2020 | $1.13 Billion | $4.28 Billion | $580.18 Million | 0.26x | 1.95x |
| 2021 | $1.76 Billion | $4.94 Billion | $665.02 Million | 0.36x | 2.65x |
| 2022 | $1.19 Billion | $5.15 Billion | $574.43 Million | 0.23x | 2.07x |
| 2023 | $1.31 Billion | $5.03 Billion | $567.26 Million | 0.26x | 2.32x |
| 2024 | $1.18 Billion | $4.07 Billion | $481.91 Million | 0.29x | 2.45x |
| 2025 | $1.16 Billion | $3.54 Billion | $393.21 Million | 0.33x | 2.94x |
Competitor Companies of 000650 by Market Capitalization
Companies near Renhe Pharmacy Co Ltd in the global market cap rankings as of November 5, 2026. Also see 000650 asset base for a full breakdown of the balance sheet.
Key companies related to Renhe Pharmacy Co Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #514 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #538 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #588 globally with a market cap of $45.79 Billion USD ( CN¥312.89 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #621 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #514 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #538 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $47.80 |
| #588 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.79 Billion | CN¥49.05 |
| #621 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of Renhe Pharmacy Co Ltd (2015–2026)
Market capitalization of Renhe Pharmacy Co Ltd from 2015 to today. Between 2015 and today, Renhe Pharmacy Co Ltd's market cap moved from $1.84 Billion to $ 1.06 Billion, with a yearly change of -4.17%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥1.06 Billion | -8.85% |
| 2025 | CN¥1.16 Billion | -1.91% |
| 2024 | CN¥1.18 Billion | -10.15% |
| 2023 | CN¥1.31 Billion | +10.53% |
| 2022 | CN¥1.19 Billion | -32.47% |
| 2021 | CN¥1.76 Billion | +55.45% |
| 2020 | CN¥1.13 Billion | -1.79% |
| 2019 | CN¥1.15 Billion | +16.89% |
| 2018 | CN¥985.86 Million | +7.05% |
| 2017 | CN¥920.97 Million | -24.83% |
| 2016 | CN¥1.23 Billion | -33.30% |
| 2015 | CN¥1.84 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Renhe Pharmacy Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.06 Billion USD |
| MoneyControl | $1.06 Billion USD |
| MarketWatch | $1.06 Billion USD |
| marketcap.company | $1.06 Billion USD |
| Reuters | $1.06 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more